Design and Evaluation of Xanthine Based Adenosine Receptor Antagonists: Potential Hypoxia Targeted Immunotherapies

Bioorganic and Medicinal Chemistry - United Kingdom
doi 10.1016/j.bmc.2013.09.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2016English

Tricyclic Imidazoline Derivatives as Potent and Selective Adenosine A1 Receptor Antagonists

English

Adenosine A2a Receptor Antagonists Attenuate Striatal Adaptations Following Dopamine Depletion

Neurobiology of Disease
Neurology
2012English

Design, Synthesis and Evaluation of Novel Angiotensin II Receptor 1 Antagonists With Antihypertensive Activities

RSC Advances
ChemistryChemical Engineering
2017English

Targeted Lysophosphatidic Acid Receptor Antagonists for Hepatocellular Carcinoma Chemoprevention

HPB
HepatologyGastroenterology
2017English

Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice

Science Translational Medicine
Medicine
2013English

Design of Subtype Selective Melatonin Receptor Agonists and Antagonists

Reproduction Nutrition Development
1999English

Past, Present and Future of A2A Adenosine Receptor Antagonists in the Therapy of Parkinson's Disease

Pharmacology and Therapeutics
Pharmacology
2011English

Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy